Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-01-25 DesRosier Thomas Chief Legal Officer and EVP Grant or award · STOCK OPTION (RIGHT TO BUY) +84,800 84,800
2019-01-25 Shaff Eric D. Grant or award · STOCK OPTION (RIGHT TO BUY) +275,000 275,000
2019-01-25 Aunins John G. Chief Technology Officer Grant or award · STOCK OPTION (RIGHT TO BUY) +60,000 60,000
2018-12-19 Aunins John G. Chief Technology Officer & EVP Exercise or conversion +10,000 85,250
2018-12-19 Aunins John G. Chief Technology Officer & EVP Exercise or conversion · RESTRICTED STOCK UNITS −10,000 0
2018-12-17 Aunins John G. Chief Technology Officer & EVP Sale −14,282 $6.39 $91K 75,250
2018-11-15 Aunins John G. Sale −14,279 $8.26 $118K 89,532
2018-10-23 HORGAN KEVIN Chief Medical Officer and EVP Grant or award · Stock Option (right to buy) +225,000 225,000
2018-10-15 Aunins John G. Sale −14,279 $5.94 $85K 103,811
2018-09-17 Aunins John G. Sale −14,279 $7.27 $104K 118,090
2018-09-07 Pomerantz Roger President and CEO Sale −1,810 $9.00 $16K 213,976
2018-09-06 Pomerantz Roger President and CEO Sale −3,013 $9.04 $27K 215,786
2018-09-05 Pomerantz Roger President and CEO Sale −9,505 $9.12 $87K 218,799
2018-08-30 Zausner Meryl Director Grant or award · Stock Option (right to buy) +30,000 30,000
2018-08-15 Aunins John G. Sale −14,279 $7.57 $108K 132,369
2018-07-15 Aunins John G. Chief Technology Officer & EVP Sale −14,279 $8.10 $116K 160,927
2018-07-11 Pomerantz Roger President and CEO Exercise or conversion +1,010 $0.71 $717 229,314
2018-07-11 Pomerantz Roger President and CEO Sale −1,010 $9.01 $9K 228,304
2018-07-11 Pomerantz Roger President and CEO Exercise or conversion · STOCK OPTION (RIGHT TO BUY) −1,010 797,536
2018-07-10 Pomerantz Roger President and CEO Exercise or conversion +5,989 $0.71 $4K 234,293

Page 26 of 34 · 662 trades